What the new Argentina guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
Recent work
243 piecesWhat the new Japan guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
Background rates, and why they matter for attribution
Pancreatitis is rare, was adjudicated in the outcome programmes, and did not show the imbalance early case reports suggested.
What the new New Zealand guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
The eighteenth month, and the conversation that should have happened in the third
A plateau at an intermediate dose and a plateau at the maximum dose look identical from the outside and mean different things.
What the new South Korea guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What the new Turkey guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
GIP was a failed target for thirty years. Then it was not.
What adding GIP activity does, on the current evidence, and what remains unresolved.
What the new Mexico guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What the new the United Kingdom guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What the new the United Arab Emirates guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What orthogonal actually means, and what it does not
Aggregates dissociate in the mobile phase and are recorded as monomer. Only a size-based separation reports them.
What the new Switzerland guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What the new India guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
The area postrema, and the anatomy of an unwanted effect
What scintigraphy and breath-test studies established about emptying rate, and what they did not.
What the trials adjudicated, and how
We give background rates alongside trial rates, because an event occurring during treatment is not thereby caused by it.
What the new Japan guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
Dose-limiting: a definition worth being strict about
An effect is dose-limiting when it prevents adequate intake, prevents normal activity, or produces a risk of its own. Discomfort alone is not the test.
Why a drug that acts on the pancreas changes what food tastes like
Receptor expression maps explain the effect profile better than any dose-response curve.
What the new Argentina guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.